Can a tablet keep kidney patients out of the hospital?
NCT ID NCT05726526
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a home monitoring system called VIEWER for people with advanced chronic kidney disease (stage 5) or end-stage renal disease. The system includes a tablet, blood pressure cuff, scale, oxygen monitor, and motion tracker. Researchers want to see if using this platform alongside usual care reduces emergency room visits and hospital stays. About 340 participants will be randomly assigned to use VIEWER or receive standard care only.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VIEWER virtual care platform (tablet, blood pressure cuff, scale, oxygen monitor, motion tracker)
What this could lead to
If successful, this could provide a way for people with advanced kidney disease to manage their health at home and avoid unnecessary hospital visits.
What could go wrong
This is a relatively small trial (340 people) testing a device, not a drug. The platform may not reduce hospital visits as hoped, and some patients may find the technology difficult to use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chronic Disease Innovation Centre, Seven Oaks Hospital
RECRUITINGWinnipeg, Manitoba, R2V 3M3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Health Sciences Centre
RECRUITINGWinnipeg, Manitoba, R3A 1R9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
London Health Sciences Centre
RECRUITINGLondon, Ontario, N6A 5W9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Scarborough Health Network - General Hospital
RECRUITINGScarborough Village, Ontario, M1P 2V5, Canada
Contact Email: •••••@•••••
-
St. Boniface Hospital
RECRUITINGWinnipeg, Manitoba, R2H 2A6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••